Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has relaunched MYFEMBREE® (relugolix/estradiol/norethindrone acetate) ...
I am a Professor of Reproductive Biology at the Department of Women's and Children's Health. With over 15 years of experience in endocrinology, reproductive biology and toxicology, I lead a research ...
1 Department of Pathology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shangdong, China 2 Department of Nuclear Medicine, The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback